BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 321.00
-3.60 (-1.11%)
Sep 18, 2026, 5:29 PM CET
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 28.48 billion as of September 18, 2026. Its market cap has increased by 16.42% in one year.
Market Cap
28.48B
Enterprise Value
26.58B
Revenue
1.00B
Ranking
n/a
PE Ratio
271.03
Stock Price
321.00
ChartMarket Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 2.55B to 28.48B, an increase of 1,015.25%. That is a compound annual growth rate of 30.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 28.48B | 3.38% |
| Dec 30, 2025 | 27.55B | 56.23% |
| Dec 30, 2024 | 17.63B | -25.44% |
| Dec 29, 2023 | 23.65B | -1.34% |
| Dec 30, 2022 | 23.97B | 128.37% |
| Dec 30, 2021 | 10.50B | 24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Camurus AB | 34.90B |
| Hansa Biopharma AB | 3.89B |
| Egetis Therapeutics AB | 3.72B |
| Vicore Pharma Holding AB | 2.91B |
| Flerie AB | 1.51B |
| BioInvent International AB | 1.47B |
| Saniona AB | 1.38B |
| Genovis AB (publ.) | 1.37B |